Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 6:9:402.
doi: 10.3389/fimmu.2018.00402. eCollection 2018.

Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis

Affiliations
Review

Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis

Skanda Rajasundaram. Front Immunol. .

Abstract

Our increasing appreciation of adenosine as an endogenous signaling molecule that terminates inflammation has generated excitement regarding the potential to target adenosine receptors (ARs) in the treatment of multiple sclerosis (MS), a disease of chronic neuroinflammation. Of the four G protein-coupled ARs, A2ARs are the principal mediator of adenosine's anti-inflammatory effects and accordingly, there is a growing body of evidence surrounding the role of A2ARs in experimental autoimmune encephalomyelitis (EAE), the dominant animal model of MS. Such evidence points to a complex, often paradoxical role for A2ARs in the immunopathogenesis of EAE, where they have the ability to both exacerbate and alleviate disease severity. This review seeks to interpret these paradoxical findings and evaluate the therapeutic promise of A2ARs. In essence, the complexities of A2AR signaling arise from two properties. Firstly, A2AR signaling downregulates the inflammatory potential of TH lymphocytes whilst simultaneously facilitating the recruitment of these cells into the CNS. Secondly, A2AR expression by myeloid cells - infiltrating macrophages and CNS-resident microglia - has the capacity to promote both tissue injury and repair in chronic neuroinflammation. Consequently, the therapeutic potential of targeting A2ARs is greatly undermined by the risk of collateral tissue damage in the periphery and/or CNS.

Keywords: adenosine; adenosine 2A receptor; experimental autoimmune encephalomyelitis; microglia; multiple sclerosis; neuroinflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Extracellular adenosine accumulates via the breakdown of ATP, both intracellularly and extracellularly. (B) A2ARs signal predominantly via the adenylate cyclase-cAMP-protein kinase A (PKA) canonical pathway (10). PKA phosphorylates the transcription factor CREB on serine residue 133; activated CREB can affect gene expression directly, via specific promoters, or indirectly, via an important cofactor, CBP. cAMP can also signal directly via the exchange factor Epac.

Similar articles

Cited by

References

    1. Coles AJ, Compston DA. Multiple sclerosis. Lancet (2008) 372:1502–17. 10.1016/S0140-6736(08)61620-7 - DOI - PubMed
    1. Dendrau CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol (2015) 15:545–58. 10.1038/nri3871 - DOI - PubMed
    1. Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol (2011) 164:1079–106. 10.1111/j.1476-5381.2011.01302.x - DOI - PMC - PubMed
    1. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol (2006) 2(4):201. 10.1038/ncpneuro0154 - DOI - PubMed
    1. Coles AJ, Compston DA, Selmaj KW. Alemtuzumab vs. interferon β-1a in early multiple sclerosis. New Engl J Med (2008) 359:1786–801. 10.1056/NEJMoa0802670 - DOI - PubMed

Publication types

Substances